Trial reportFrontiers in public health2025
Efficacy of neurofeedback-assisted mindfulness for anxiety and nomophobia in Spanish young adults: a randomized controlled trial.
Trial report in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06188910 (Effectiveness of a Neurofeedback Intervention on Symptoms of Anxiety and Psychological Distress Associated With Smartphone Use in Young Adults), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effectiveness of a Neurofeedback Intervention on Symptoms of Anxiety and Psychological Distress Associated With Smartphone Use in Young Adults
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Problematic use of new technologies has been associated with anxiety and other disorders in young adults. This study evaluated the efficacy of a Neurofeedback-Assisted Mindfulness Training Program (NAMTP) in reducing anxiety and related symptoms in young adults. Methods: A randomized clinical trial assigned participants to an intervention group (IG), receiving 20-25 NAMTP sessions, or a control group (CG). All participants received a brief workshop on responsible technology use. Anxiety was assessed using the DASS-21 anxiety subscale. Secondary outcomes included the Smartphone Addiction Scale-Short Version (SAS-SV), Nomophobia Questionnaire (NMP-Q), and Athens Insomnia Scale (AIS), all evaluated at baseline and three months. Results: A total of 40 participants completed the study (82.5% women; mean age 24.8 ± 3.4). No statistically significant differences were observed between the intervention group (IG) and the control group (CG) in any of the psychological variables assessed. For the DASS scales, the mean differences (IG-CG) were 0.1 (95% CI: -1.6 to 1.9; Conclusions: The NAMTP did not produce significant improvements in anxiety, mobile phone addiction, nomophobia, or sleep quality. These findings suggest that, although NAMTP is feasible and well-tolerated, further research is needed to determine its potential benefits. Trial registration: Clinicaltrials.gov; NCT06188910. http://www.Clinicaltrials.gov/ct2/show/NCT06188910.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.